ResMed (RMD) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.99 -1.5%
Revenue Growth %: +6.9%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.9%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.88, $0.10 better than the analyst estimate of $1.78. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.15 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
